Toronto (October 19, 2020) – The Leukemia and Lymphoma Society of Canada (LLSC) is pleased to announce the appointment of Jennifer Marley, a new Chair to the LLSC Board of Directors.
“I am very pleased to welcome Jennifer to our leadership team,” said Alicia Talarico, LLSC’s president. “She is a seasoned executive and brings a wealth of experience in marketing, branding, culture and engagement. Jennifer’s personal experience with a blood cancer represents a tremendous addition to our organization, and I am confident that her considerable insight and breadth of experience will be invaluable to our team as we work together to serve those newly diagnosed, people in treatment and those navigating life after a blood cancer.”
The Leukemia & Lymphoma Society of Canada is the single largest voluntary health agency dedicated to all blood cancers in Canada. LLSC funds life-saving blood cancer research across the country, and provides information and support services free of charge to people affected by a blood cancer and their families. Its mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of Canadians affected by blood cancers.
LLSC’s Board of Directors is comprised of seasoned leaders from the medical, business, academic and volunteer communities in Canada. It is the Board’s responsibility to provide governance, counsel and guidance in the strategic direction of the Leukemia and Lymphoma Society of Canada, as well as, to raise awareness of its research program and support services that help support Canadians at every step of their blood cancer experience.
A proven marketing strategy and insights leader with over 30 years of experience, Jennifer Marley solves the highest-level, toughest strategic challenges for her clients at the strategy and insights advisory firm, Sklar Wilton & Associates (SW&A). In her 20 years at SW&A, Jennifer has been honoured to work with some of Canada’s finest companies to collaboratively help them build stronger brands to unlock growth. Her vision has been a driving force behind many successful culture, engagement and coaching initiatives at SW&A leading the firm to be named as one of Canada’s Best Workplaces, as well as, an Employee Recommended Workplace in 2017, 2018, 2019 and 2020. The blood cancer cause is a personal one for Jennifer. She is a 16-year leukemia survivor and is a dedicated volunteer for The Leukemia & Lymphoma Society of Canada.